# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003477
Filing Date
2021-11-08
Accepted
2021-11-08 16:21:26
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | oric-20210930.htm iXBRL | 10-Q | 2772206
2 | EX-10.2 | oric-ex10_2.htm | EX-10.2 | 188977
3 | EX-31.1 | oric-ex31_1.htm | EX-31.1 | 17021
4 | EX-31.2 | oric-ex31_2.htm | EX-31.2 | 17008
5 | EX-32.1 | oric-ex32_1.htm | EX-32.1 | 10383
6 | EX-32.2 | oric-ex32_2.htm | EX-32.2 | 10369
| Complete submission text file | 0000950170-21-003477.txt |  | 7834440

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | oric-20210930_lab.xml | EX-101.LAB | 353576
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | oric-20210930_pre.xml | EX-101.PRE | 245451
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | oric-20210930_def.xml | EX-101.DEF | 125168
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | oric-20210930_cal.xml | EX-101.CAL | 41108
11 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | oric-20210930.xsd | EX-101.SCH | 38161
12 | EXTRACTED XBRL INSTANCE DOCUMENT | oric-20210930_htm.xml | XML | 1228914

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39269 | Film No.: 211388296
SIC: 2834 Pharmaceutical Preparations